share_log

Insider Sale: Insider at $BWIN (BWIN) Sells 88,306 Shares

Insider Sale: Insider at $BWIN (BWIN) Sells 88,306 Shares

內部人士出售:$BWIN (BWIN) 的內部人士出售了88,306股
Quiver Quantitative ·  12/12 07:16

Elizabeth Krystyn, an insider at $BWIN ($BWIN), sold 88,306 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares. Following this trade, they now own 0 shares of $BWIN stock.

$BWIN($BWIN)的內部人士伊麗莎白·克里斯汀於2024年11月12日出售了該公司的88,306股股票。我們從美國證券交易委員會最近的一份文件中收到了交易數據。這是他們約100.0%的股份的出售。在這筆交易之後,他們現在擁有0股$BWIN股票。

$BWIN Insider Trading Activity

$BWIN 內幕交易活動

$BWIN insiders have traded $BWIN stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

在過去的6個月中,$BWIN內部人士在公開市場上交易了26次BWIN股票。在這些交易中,0筆是購買,26筆是銷售。

Here's a breakdown of recent trading of $BWIN stock by insiders over the last 6 months:

以下是內部人士在過去6個月中對$BWIN股票的近期交易明細:

  • ELIZABETH KRYSTYN has traded it 6 times. They made 0 purchases and 6 sales, selling 423,877 shares.
  • LOWRY BALDWIN has traded it 5 times. They made 0 purchases and 5 sales, selling 150,000 shares.
  • DANIEL GALBRAITH (See Remarks) sold 75,000 shares.
  • JAMES MORGAN ROCHE (See Remarks) has traded it 12 times. They made 0 purchases and 12 sales, selling 524,653 shares.
  • BRADFORD HALE (Chief Financial Officer) sold 10,000 shares.
  • SETH BALA COHEN (General Counsel) sold 3,783 shares.
  • ELIZABETH KRYSTYN 已經交易了 6 次。他們進行了0次買入和6次銷售,賣出了423,877股股票。
  • 洛瑞·鮑德溫已經交易了5次。他們進行了0次購買和5次銷售,出售了15萬股股票。
  • 丹尼爾·加爾佈雷思(見備註)出售了7.5萬股股票。
  • 詹姆斯摩根羅氏(見備註)已經進行了12次交易。他們進行了0次買入和12次銷售,賣出了524,653股股票。
  • 布拉德福德·黑爾(財務長)出售了1萬股股票。
  • 塞思·巴拉·科恩(總法律顧問)出售了3,783股股票。

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

要追蹤內幕交易,請查看Quiver Quantization的內幕交易儀表板。


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

本文不是財務建議。有關更多信息,請參閱 Quiver Quitizative 的免責聲明。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論